Shares of Zymeworks were higher after the Food and Drug Administration cleared the company's investigational new drug application for its treatment for liver cancer. The stock rose 8.5%, to $14.46, in ...

Dow Jones futures rose modestly early Monday, along with S&P 500 futures and Nasdaq futures. The U.S. and European Union ...

Celcuity said its Phase 3 clinical trial evaluating gedatolisib resulted in positive topline results. The clinical-stage biotechnology company's trial evaluated gedatolisib plus fulvestrant with and ...

While Dow Jones futures were up 0.16% at the time of writing, the S&P 500 futures surged 0.25%, and the tech-heavy Nasdaq 100 ...

In the middle of the month, the 50-day moving average exceeded the 200-day moving average, a signal known as a “golden cross.

U.S. stock futures and European indexes gained, while the dollar strengthened against the euro, after President Trump announced the trade agreement Sunday. The pact imposes a baseline tariff of 15% on ...

New account openings across four big lenders were down 5% in the second quarter from a year earlier. The lender forecast total income excluding notable items to exceed $21.61 billion as loan growth ...

Markets today face a packed week with earnings, Fed signals, and key jobs data likely to guide direction into month-end.

The news eased fears of a harmful trade war and boosted market sentiment, putting stocks on track to resume a rally that saw the S&P 500 notch its fifth all-time high in a row on ...

Dow Jones Industrial Average trades at 44,901.92, approaching record territory. S&P 500 hits new highs amid Japan trade deal, ...

Wall Street futures ticked up on Monday, fueled by a U.S.–EU trade pact that set an upbeat tone for a high-stakes week ...